• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 68 of 100
One analyst thinks Mylan's EpiPen price hike ties back to its executive incentive plans.
HealthMylan’s EpiPen Problems Just Got a Whole Lot Worse
By Sy Mukherjee and ReutersSeptember 6, 2016
PillPack
FinancePillPack Is Raising More Money to Take On Pharmacies
By Dan PrimackSeptember 6, 2016
Biogen Drug Shows Early Promise against Alzheimer’s Disease
TechBiogen Drug Shows Early Promise against Alzheimer’s Disease
By David Z. MorrisSeptember 3, 2016
Democratic Presidential candidate and former U.S. Secretary of State Hillary Clinton Campaigns In Iowa
LeadershipHillary Clinton Says You Won’t See Price Hikes On Life-Saving Drugs if She’s Elected
By ReutersSeptember 2, 2016
FRANCE-POLITICS-INDUSTRY
HealthU.S. Headwinds Force Change of CEO at Novo Nordisk
By ReutersSeptember 1, 2016
The Davos World Economic Forum 2015
HealthNovartis Just Got Some Great News in Its Battle for Amgen’s Market Share
By Sy MukherjeeAugust 31, 2016
Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion
FinanceAlere Is Suing to Force Abbott to Complete Their $5.8 Billion Merger
By ReutersAugust 26, 2016
US-HEALTH-DRUGS-CONSUMER-POLITICS-MYLAN
FinanceWhat Mylan’s EpiPen Cost Scandal Says About the Drug Price Problem
By Jen WiecznerAugust 25, 2016
Fortune Most Powerful Women Summit 2015
HealthMylan Halves EpiPen Price After Being Savaged by Clinton
By Reuters and Fortune EditorsAugust 25, 2016
Mylan NV Chief Executive Officer Heather Bresch Interview
FinanceMylan CEO Blamed Obamacare for EpiPen Sticker Shock
By Jen WiecznerAugust 24, 2016
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
FinanceHere’s Why Mylan Has Something to Be Happy About Today
By Lucinda ShenAugust 24, 2016
Democratic Presidential Nominee Hillary Clinton Delivers Speech On The Economy
HealthPharma Bro Martin Shkreli Takes On Hillary Clinton Over Mylan’s EpiPen
By Sy MukherjeeAugust 24, 2016
A sign is seen at an AstraZeneca site in Macclesfield
HealthAstraZeneca Is Selling Its Antibiotics Business to Pfizer
By Reuters and Michelle TohAugust 24, 2016
Senator Amy Klobuchar, D-MN, listens to
HealthLawmakers Are Demanding Investigations Into Mylan’s Huge EpiPen Price Hike
By Sy MukherjeeAugust 23, 2016
Amid debate on drug prices, California leads way on cost controls
HealthHow Mylan Got Away With Its Enormous Price Hike for the EpiPen
By Sy MukherjeeAugust 22, 2016
1...
  • 66
  • 67
  • 68
  • 69
  • 70
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Future of Work
Palantir CEO says AI ‘will destroy’ humanities jobs but there will be ‘more than enough jobs’ for people with vocational trainingplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
The 'affordability economy' has created a housing market nobody predicted: Prices collapsing in the Sun Belt, soaring in the Rust Beltplaceholder alt text
By Fortune EditorsApril 11, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.